StockData
Immunome Inc. logo

Immunome Inc. (IMNM) stock

IMNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$16.78−0.40 (-2.33%)

Close on Nov 18, 2026Market cap $1.91BP/E –Yield –

Immunome shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Immunome's shares outstanding was 113M at Mar 31, 2026. For fiscal 2025 it was 87M, up 49.0% from the year before. The highest annual figure on record is 87M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202587M+49.0%
FY2024Dec 31, 202459M+195.5%
FY2023Dec 31, 202320M+63.6%
FY2022Dec 31, 202212M+5.1%
FY2021Dec 31, 202112M+240.4%
FY2020Dec 31, 20203M+209.8%
FY2019Dec 31, 20191M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2026Mar 31, 2026113M+42.5%
Q4 FY2025Dec 31, 202595M+51.1%
Q3 FY2025Sep 30, 202588M+46.1%
Q2 FY2025Jun 30, 202587M+45.2%
Q1 FY2025Mar 31, 202579M+54.1%
Q4 FY2024Dec 31, 202463M+415.0%
Q3 FY2024Sep 30, 202460M+393.6%
Q2 FY2024Jun 30, 202460M+392.0%
Q1 FY2024Mar 31, 202452M+325.0%
Q3 FY2023Sep 30, 202312M+0.6%
Q2 FY2023Jun 30, 202312M+0.6%
Q1 FY2023Mar 31, 202312M+0.5%
Q4 FY2022Dec 31, 202212M+0.2%
Q3 FY2022Sep 30, 202212M+1.6%
Q2 FY2022Jun 30, 202212M+5.9%
Q1 FY2022Mar 31, 202212M+13.9%
Q4 FY2021Dec 31, 202112M+986.5%
Q3 FY2021Sep 30, 202112M+980.7%
Q2 FY2021Jun 30, 202111M+942.2%
Q1 FY2021Mar 31, 202111M+869.2%
Q3 FY2020Sep 30, 20201M+2.0%
Q2 FY2020Jun 30, 20201M–
Q1 FY2020Mar 31, 20201M–
Q4 FY2019Dec 31, 20191M–
Q3 FY2019Sep 30, 20191M–

More Immunome figures

See a number that looks wrong?